BioCube (BioCube) Cash And Cash Equivalents : $0.00 Mil (As of Jul. 2013)

View and export this data going back to 2007. Start your Free Trial

What is BioCube Cash And Cash Equivalents?

BioCube's annual cash and cash equivalents declined from Jan. 2011 ($0.00 Mil) to Jan. 2012 ($0.00 Mil) and declined from Jan. 2012 ($0.00 Mil) to Jan. 2013 ($0.00 Mil).

BioCube Cash And Cash Equivalents Historical Data

The historical data trend for BioCube's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCube Cash And Cash Equivalents Chart

BioCube Annual Data

Trend

Jun06

Jun07

Jan08

Jan09

Jan11

Jan12

Jan13

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.50

1.09

BioCube Quarterly Data
	Apr08	Jul08	Oct08	Jan09	Apr09	Oct09	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13
Cash And Cash Equivalents	Get a 7-Day Free Trial															-	-	-	-	-

BioCube Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

BioCube (OTCPK:BICB) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

BioCube Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of BioCube's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

BioCube (BioCube) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » BioCube Inc (OTCPK:BICB) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

3060 West 3680 South, Suite 92, West Valley, UT, USA, 84119

Website

http://www.biocubeinc.com

BioCube Inc is a shell company.

Executives

Jan E Chason	director	120 WALL STREET, SUITE 2401, NEW YORK NY 10005
Jonathan Gilbert	director	36 SYCAMORE LANE, ROSALYN HEIGHTS NY 11577
Gregory D Cohen	director, officer: Chief Executive Officer	336 WEST 37TH STREET, 8TH FLOOR, NEW YORK NY 10019

BioCube (BioCube) Headlines

No Headlines